Appointment booking for Dr. Felix De Jesus Roman, MD is currently not available.Dr. Felix De Jesus Roman, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Felix De Jesus Roman, MD (he/him) is a Internist in Naugatuck, CT with over 10 years of experience. What is your opinion of Dr. Felix De Jesus Roman, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 10 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Felix De Jesus Roman, MD has received over $2,129 which includes payments from the following companies:
$346.06 from AstraZeneca Pharmaceuticals LP
$333.49 from Boehringer Ingelheim Pharmaceuticals, Inc.
$298.89 from Pfizer Inc.
$278.48 from LILLY USA, LLC
$125.00 from Janssen Pharmaceuticals, Inc
$121.36 from GlaxoSmithKline, LLC.
$119.24 from Amgen Inc.
$107.35 from Novo Nordisk Inc
$91.95 from Salix Pharmaceuticals, a division of Bausch Health US, LLC
$75.40 from Astellas Pharma US Inc
$47.01 from AbbVie, Inc.
$44.20 from Merck Sharp & Dohme Corporation
$37.47 from Eisai Inc.
$36.09 from Endo Pharmaceuticals Inc.
$28.28 from Novartis Pharmaceuticals Corporation
$21.28 from Biohaven Pharmaceuticals, Inc.
$17.53 from Allergan Inc.
Payments received by Dr. Felix De Jesus Roman, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!